BioSante Pharmaceuticals, Inc. (BPAX)
-NasdaqGM 1.22 
0.04(3.17%) 20 Jun 03:59 SGT
| Prev Close: | 1.26 |
|---|
| Open: | 1.25 |
|---|
| Bid: | 1.21 x 10000 |
|---|
| Ask: | 1.34 x 900 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 2.11 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.22 - 1.28 |
|---|
| 52wk Range: | 1.01 - 2.75 |
|---|
| Volume: | 98,181 |
|---|
| Avg Vol (3m): | 191,325 |
|---|
| Market Cap: | 29.87M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.86 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Leading Independent Proxy Advisory Firms ISS and Glass, Lewis & Co., LLC Recommend Vote “FOR” BioSante/ANI MergerBusiness Wire(Mon, 10 Jun)
- BIOSANTE PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Wed, 22 May)
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial ResultsBusiness Wire(Sat, 11 May)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Fri, 10 May)
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed MergerBusiness Wire(Thu, 9 May)
- Huge Potential But Tough Entry For Female Sexual Dysfunction Drugsat Seeking Alpha(Wed, 8 May)
- 4 Bio Stocks to Buy Todayat Motley Fool(Wed, 1 May)
- Ceregene Reports Data From Parkinson's Disease Phase 2b StudyPR Newswire(Sat, 20 Apr)
- BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger AgreementBusiness Wire(Sat, 13 Apr)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a MateriaEDGAR Online(Fri, 12 Apr)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 13.23 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
BioSante Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development of products for female sexual health, menopause, contraception, and male hypogonadism.
View More